In the early 1900s, with the advent of new medical therapies and disease perspectives, novel strategies were employed to promote weight loss including thyroid hormone supplementation, and later, amphetamines [1]
Research with senescent rhesus monkeys (aged 20-27 years) showed that Epithalon administration decreased basal plasma levels of glucose and insulin while increasing basal nighttime melatonin levelsreversing age-associated endocrine dysfunction patterns
These are individualized cases, but ideal candidates are those open to trying a novel therapy in addition to conventional ones to achieve the best outcome
Among these, CLRs play a central and synergistic role
AOD 9604 is a synthetic peptide fragment derived from human growth hormone (HGH)
Because oral therapy is lengthy, carries potential hepatic side effects, and requires monitoring, some patients may prefer conservative management, keeping nails short, improving foot hygiene, and using antifungal powders to limit spread